Long-Term Quality of Life and Pregnancy Outcomes of Differentiated Thyroid Cancer Survivors Treated by Total Thyroidectomy and I131 during Adolescence and Young Adulthood
Table 1
Clinical and demographic characteristics of patients diagnosed and treated with differentiated thyroid cancer before age of 25 years.
Cumulative dose of I131
≤3.85 GBq
>3.85 GBq
Number
18
27
Diagnosis before age of 18 years (yes)
5 (28%)
12 (44%)
Age at diagnosis (years)
19.9 ± 3
19.3 ± 3.9
Actual age (years)
27.7 ± 6.7
36.1 ± 11.1
Time since diagnosis (years)
7.6 ± 5.2
16.9 ± 11.6
Histology
Papillary
16
25
Follicular
2
2
TNM stage
T?
0
4
T1
7
3
T2
10
10
T3
1
6
T4
0
4
N0
15
8
N1
3
19
M0
18
23
M1
0
4
Administration of I131
Age at first treatment
19.9 ± 3
19.3 ± 3.9
Cumulative dose
3.54 ± 0.47
8.25 ± 1.64
Number of administration times
0.96 ± 0.2
2.7 ± 1.7
Marital status
Single
10
6
Engaged
5
8
Married
3
11
Divorced
0
1
Missing
0
1
Education level
Without diploma
1
1
Professional diploma
1
9
“Bac-level” diploma
9
10
University studies
12
15
Missing
0
1
Profession
Student
6
3
Professional activity (yes)
8
21
Smoking
No
11
6
Active
6
1
Stopped
1
20
IMC (kg/m2)
25.9 ± 4
23.7 ± 5
Data are presented as mean (±SD) or number (percentage). ; .
